Interleukin-6 and interleukin-1 receptor antagonist in acute stroke

Nancy B. Beamer, Bruce M. Coull, Wayne Clark, J. Samantha Hazel, Jenny R. Silberger

Research output: Contribution to journalArticle

205 Citations (Scopus)

Abstract

Elevated plasma levels of interleukin-6 (IL-6), a key regulator of the acute phase response that includes increased fibrinogen synthesis, have recently been detected in patients with acute stroke. Nevertheless, the role of the acute phase response in stroke has been controversial, with some studies suggesting that preexisting infection accounts for most of the acute phase response. Increased IL-6 could signal the involvement of antiinflammatory activity, since IL-6 stimulates the production of endogenous antiinflammatory mediators such as interleukin-1 receptor antagonist (IL- IRA). To better understand the interaction of pro- and antiinflammatory acute phase processes in brain infarction, plasma levels of IL-1RA, IL-6, and acute phase proteins including fibrinogen and c-reactive protein (CRP) were measured within 4 ± 2 days of onset in 50 patients with acute ischemic stroke and in 20 age-matched healthy controls. After excluding patients with evidence of infection, both IL-1RA and IL-6 were significantly elevated in stoke patients compared with controls (p <0.0001). IL-1RA and IL-6 were both significantly correlated with levels of CRP, p <0.05 and p <0.001, respectively, but not with each other. Levels of IL-6 and IL-1RA, together with fibrinogen and CRP were higher in patients with infarcts of greater than 3 cm and lowest in patients with lacunar syndromes. Detection of increased peripheral levels of IL-1RA, IL-6, and additional acute phase reactants, including CRP, in acute stroke uncomplicated by infection suggests that an acute phase response to brain infarction occurs and that the magnitude of this response may be related to the volume of infarcted brain.

Original languageEnglish (US)
Pages (from-to)800-804
Number of pages5
JournalAnnals of Neurology
Volume37
Issue number6
DOIs
StatePublished - Jun 1995

Fingerprint

Interleukin-1 Receptors
Interleukin-6
Stroke
Acute-Phase Reaction
Fibrinogen
Brain Infarction
Anti-Inflammatory Agents
Acute-Phase Proteins
Proteins
Infection
Lacunar Stroke
Brain

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Beamer, N. B., Coull, B. M., Clark, W., Hazel, J. S., & Silberger, J. R. (1995). Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Annals of Neurology, 37(6), 800-804. https://doi.org/10.1002/ana.410370614

Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. / Beamer, Nancy B.; Coull, Bruce M.; Clark, Wayne; Hazel, J. Samantha; Silberger, Jenny R.

In: Annals of Neurology, Vol. 37, No. 6, 06.1995, p. 800-804.

Research output: Contribution to journalArticle

Beamer, NB, Coull, BM, Clark, W, Hazel, JS & Silberger, JR 1995, 'Interleukin-6 and interleukin-1 receptor antagonist in acute stroke', Annals of Neurology, vol. 37, no. 6, pp. 800-804. https://doi.org/10.1002/ana.410370614
Beamer, Nancy B. ; Coull, Bruce M. ; Clark, Wayne ; Hazel, J. Samantha ; Silberger, Jenny R. / Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. In: Annals of Neurology. 1995 ; Vol. 37, No. 6. pp. 800-804.
@article{b46e2082ccdf4b46a88eeeb9498a2e46,
title = "Interleukin-6 and interleukin-1 receptor antagonist in acute stroke",
abstract = "Elevated plasma levels of interleukin-6 (IL-6), a key regulator of the acute phase response that includes increased fibrinogen synthesis, have recently been detected in patients with acute stroke. Nevertheless, the role of the acute phase response in stroke has been controversial, with some studies suggesting that preexisting infection accounts for most of the acute phase response. Increased IL-6 could signal the involvement of antiinflammatory activity, since IL-6 stimulates the production of endogenous antiinflammatory mediators such as interleukin-1 receptor antagonist (IL- IRA). To better understand the interaction of pro- and antiinflammatory acute phase processes in brain infarction, plasma levels of IL-1RA, IL-6, and acute phase proteins including fibrinogen and c-reactive protein (CRP) were measured within 4 ± 2 days of onset in 50 patients with acute ischemic stroke and in 20 age-matched healthy controls. After excluding patients with evidence of infection, both IL-1RA and IL-6 were significantly elevated in stoke patients compared with controls (p <0.0001). IL-1RA and IL-6 were both significantly correlated with levels of CRP, p <0.05 and p <0.001, respectively, but not with each other. Levels of IL-6 and IL-1RA, together with fibrinogen and CRP were higher in patients with infarcts of greater than 3 cm and lowest in patients with lacunar syndromes. Detection of increased peripheral levels of IL-1RA, IL-6, and additional acute phase reactants, including CRP, in acute stroke uncomplicated by infection suggests that an acute phase response to brain infarction occurs and that the magnitude of this response may be related to the volume of infarcted brain.",
author = "Beamer, {Nancy B.} and Coull, {Bruce M.} and Wayne Clark and Hazel, {J. Samantha} and Silberger, {Jenny R.}",
year = "1995",
month = "6",
doi = "10.1002/ana.410370614",
language = "English (US)",
volume = "37",
pages = "800--804",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Interleukin-6 and interleukin-1 receptor antagonist in acute stroke

AU - Beamer, Nancy B.

AU - Coull, Bruce M.

AU - Clark, Wayne

AU - Hazel, J. Samantha

AU - Silberger, Jenny R.

PY - 1995/6

Y1 - 1995/6

N2 - Elevated plasma levels of interleukin-6 (IL-6), a key regulator of the acute phase response that includes increased fibrinogen synthesis, have recently been detected in patients with acute stroke. Nevertheless, the role of the acute phase response in stroke has been controversial, with some studies suggesting that preexisting infection accounts for most of the acute phase response. Increased IL-6 could signal the involvement of antiinflammatory activity, since IL-6 stimulates the production of endogenous antiinflammatory mediators such as interleukin-1 receptor antagonist (IL- IRA). To better understand the interaction of pro- and antiinflammatory acute phase processes in brain infarction, plasma levels of IL-1RA, IL-6, and acute phase proteins including fibrinogen and c-reactive protein (CRP) were measured within 4 ± 2 days of onset in 50 patients with acute ischemic stroke and in 20 age-matched healthy controls. After excluding patients with evidence of infection, both IL-1RA and IL-6 were significantly elevated in stoke patients compared with controls (p <0.0001). IL-1RA and IL-6 were both significantly correlated with levels of CRP, p <0.05 and p <0.001, respectively, but not with each other. Levels of IL-6 and IL-1RA, together with fibrinogen and CRP were higher in patients with infarcts of greater than 3 cm and lowest in patients with lacunar syndromes. Detection of increased peripheral levels of IL-1RA, IL-6, and additional acute phase reactants, including CRP, in acute stroke uncomplicated by infection suggests that an acute phase response to brain infarction occurs and that the magnitude of this response may be related to the volume of infarcted brain.

AB - Elevated plasma levels of interleukin-6 (IL-6), a key regulator of the acute phase response that includes increased fibrinogen synthesis, have recently been detected in patients with acute stroke. Nevertheless, the role of the acute phase response in stroke has been controversial, with some studies suggesting that preexisting infection accounts for most of the acute phase response. Increased IL-6 could signal the involvement of antiinflammatory activity, since IL-6 stimulates the production of endogenous antiinflammatory mediators such as interleukin-1 receptor antagonist (IL- IRA). To better understand the interaction of pro- and antiinflammatory acute phase processes in brain infarction, plasma levels of IL-1RA, IL-6, and acute phase proteins including fibrinogen and c-reactive protein (CRP) were measured within 4 ± 2 days of onset in 50 patients with acute ischemic stroke and in 20 age-matched healthy controls. After excluding patients with evidence of infection, both IL-1RA and IL-6 were significantly elevated in stoke patients compared with controls (p <0.0001). IL-1RA and IL-6 were both significantly correlated with levels of CRP, p <0.05 and p <0.001, respectively, but not with each other. Levels of IL-6 and IL-1RA, together with fibrinogen and CRP were higher in patients with infarcts of greater than 3 cm and lowest in patients with lacunar syndromes. Detection of increased peripheral levels of IL-1RA, IL-6, and additional acute phase reactants, including CRP, in acute stroke uncomplicated by infection suggests that an acute phase response to brain infarction occurs and that the magnitude of this response may be related to the volume of infarcted brain.

UR - http://www.scopus.com/inward/record.url?scp=0029076766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029076766&partnerID=8YFLogxK

U2 - 10.1002/ana.410370614

DO - 10.1002/ana.410370614

M3 - Article

VL - 37

SP - 800

EP - 804

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 6

ER -